Log in to save to my catalogue

Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with...

Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2573454530

Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study

About this item

Full title

Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study

Publisher

United States: Public Library of Science

Journal title

PLoS medicine, 2021-08, Vol.18 (8), p.e1003732

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

The standard of care treatment for muscle-invasive bladder cancer (MIBC) is radical cystectomy, which is typically preceded by neoadjuvant chemotherapy. However, the inability to assess minimal residual disease (MRD) noninvasively limits our ability to offer bladder-sparing treatment. Here, we sought to develop a liquid biopsy solution via urine tu...

Alternative Titles

Full title

Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2573454530

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2573454530

Other Identifiers

ISSN

1549-1676,1549-1277

E-ISSN

1549-1676

DOI

10.1371/journal.pmed.1003732

How to access this item